These findings align with our demonstration that the most distinct IFN signature was expressed by monocytic and CD4 IFN+ cells from patients with SJIA-MAS, with a lesser degree of elevated expression of these genes for monocytes from active SJIA and SJIA-LD. The gene discussed is IFNA1; the disease is macrophage activation syndrome.